Publikationen, an denen er mitarbeitet Fernando Bandrés Moya (12)

2023

  1. Prognostic Significance of Amino Acid and Biogenic Amines Profiling in Chronic Kidney Disease

    Biomedicines, Vol. 11, Núm. 10

2019

  1. Association of HTR2A-1438G/A Genetic Polymorphism With Smoking and Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 55, Núm. 3, pp. 128-133

  2. Physical performance and quality of life in older adults: Is there any association between them and potential drug interactions in polymedicated octogenarians

    International Journal of Environmental Research and Public Health, Vol. 16, Núm. 21

2017

  1. A Paradox: α-Klotho Levels and Smoking Intensity

    Lung, Vol. 195, Núm. 1, pp. 53-57

2016

  1. Effect of genetic polymorphisms and long-term tobacco exposure on the risk of breast cancer

    International Journal of Molecular Sciences, Vol. 17, Núm. 10

  2. The effect of polymorphisms in DNA repair genes and carcinogen metabolizers on leukocyte telomere length: A cohort of healthy Spanish smokers

    Nicotine and Tobacco Research, Vol. 18, Núm. 4, pp. 447-452

2015

  1. Are SNP-Smoking association studies needed in controls? DNA repair gene polymorphisms and smoking intensity

    PLoS ONE, Vol. 10, Núm. 5

  2. Effects of cigarette smoking and nicotine metabolite ratio on leukocyte telomere length.

    Environmental Research, Vol. 140, pp. 488-494

2014

  1. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6 ?

    Pharmacopsychiatry, Vol. 47, Núm. 1, pp. 33-36

2011

  1. 'Smoking Genes': A genetic association study

    PLoS ONE, Vol. 6, Núm. 10

2010

  1. A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants

    PLoS ONE, Vol. 5, Núm. 6

2009

  1. Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORCI c.-l 639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 591-593